VEGFA and chronic kidney disease: The clinical usefulness of angiogenesis-associated factors, such as VEGF-A, sVEGFR-1/2 and Angiopoietin-1/2, in CKD patients has recently been demonstrated [34], [35], [36], [37], [38], [39].